Magazine Article | July 1, 2020

A Quick Transition From Research Firm To Clinical-Phase Biotech

Source: Life Science Leader

By Ed Miseta, Chief Editor, Clinical Leader
Follow Me On Twitter @EdClinical

To say the last two years have been a whirlwind for Anne Whitaker would likely be an understatement.

In October 2018, with more than two decades of senior-level leadership experience in the pharma industry, Anne Whitaker joined small biotech Dance Biopharma as its CEO. Nearly a year later she helped spearhead a name change to Aerami Therapeutics and a move of its headquarters to Durham, NC. Oh, and throughout all of that she had to figure out how to transition the company from a research firm to a clinical-phase company. It’s been a complicated and challenging journey.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: